Together, this suggests that DMS and SKI II reduce HIV transmission in CD4 T cells by lowering susceptibility to infection via reduction of SAMHD1 phosphorylation (resulting in a relative increase in the active form of the restriction factor), with a reduction in CD4 surface density by DMS contributing to the inhibitory effect of this compound. Here, CD4 is linked to infection.